Robert Lischke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Robert Lischke has a total of 293 co-authors. Here are the top co-authors by number of shared publications:
- P Pafko
III. chirurgická klinika 1. LF UK, FN Motol, Praha
27 shared publications - Alan J. Stolz
III. chirurgická klinika 1. LF UK a FN Motol, Praha
18 shared publications - Pavel Pafko
43rd Department of Surgery, 1st Faculty of Medicine, Charles University in Prague and University Hospital in Motol, Prague 121 08, Czech Republic
18 shared publications - J Schutzner
III. Chirurgická klinika 1. LF UK a FNM, Praha
17 shared publications - Jan Schutzner
3rd Department of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
16 shared publications - Jan Simonek
Prague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
14 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by Elsevier in American Journal of Transplantation
Molecular diagnosis of T cell–mediated rejection in bronchial mucosal and transbronchial biopsies
- 25 September 2026
- Published by Elsevier in American Journal of Transplantation
Open AccessMolecular diagnosis of T cell–mediated rejection in bronchial mucosal and transbronchial biopsies
- 23 May 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (10) , 1711-1712
Response to “Letter to the editor” from Dr. Paul Corris
- 23 May 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (10) , 1711-1712
Response to “Letter to the editor” from Dr. Paul Corris
- Open Access
- 14 February 2026
- Published by Elsevier in Cancer Epidemiology
- Vol. 101, 103019
Does motherhood increase the risk of developing subsequent malignant neoplasms after childhood cancer treatment?
- 14 February 2026
- Published by Elsevier in Cancer Epidemiology
- Vol. 101, 103019
Open AccessDoes motherhood increase the risk of developing subsequent malignant neoplasms after childhood cancer treatment?
- 13 January 2026
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 72 (11) , e339-e347
Viscoelastic Testing to Guide Anticoagulation During Extracorporeal Membrane Oxygenation in Lung Transplantation
Extracorporeal membrane oxygenation (ECMO) represents an established modality of intraoperative circulatory and respiratory support during lung transplantation (LTx). Systemic anticoagulation with unfractionated heparin (UFH) remains essential to prevent circuit thrombosis; however, the optimal monitoring strategy during this procedure remains uncertain. Conventional assays, including antifactor Xa activity (anti-Xa), activated partial thromboplastin time (aPTT), aPTT ratio (aPTTr), and activated clotting time (ACT), demonstrate variable sensitivity and reliability, particularly at low UFH concentrations where ACT is often inadequate. This study aimed to evaluate the interrelationship between standard coagulation monitoring methods and to assess the feasibility of using viscoelastic testing, specifically the ROTEM INTEM/HEPTEM clotting time ratio (I/Hr), as a bedside alternative to ACT. A total of 79 patients undergoing LTx with intraoperative ECMO support were analyzed. Unfractionated heparin was administered in all cases, and coagulation parameters were assessed preoperatively, before ECMO cannulation, and during ECMO support. A strong correlation was observed between I/Hr and anti-Xa, with satisfactory agreement with aPTT and aPTTr. Bland–Altman analysis confirmed narrower limits of agreement for I/Hr-derived versus ACT-derived anti-Xa predictions. These findings support I/Hr as a reliable and practical bedside surrogate for UFH monitoring during ECMO-assisted LTx.
- 13 January 2026
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 72 (11) , e339-e347
Viscoelastic Testing to Guide Anticoagulation During Extracorporeal Membrane Oxygenation in Lung Transplantation
Extracorporeal membrane oxygenation (ECMO) represents an established modality of intraoperative circulatory and respiratory support during lung transplantation (LTx). Systemic anticoagulation with unfractionated heparin (UFH) remains essential to prevent circuit thrombosis; however, the optimal monitoring strategy during this procedure remains uncertain. Conventional assays, including antifactor Xa activity (anti-Xa), activated partial thromboplastin time (aPTT), aPTT ratio (aPTTr), and activated clotting time (ACT), demonstrate variable sensitivity and reliability, particularly at low UFH concentrations where ACT is often inadequate. This study aimed to evaluate the interrelationship between standard coagulation monitoring methods and to assess the feasibility of using viscoelastic testing, specifically the ROTEM INTEM/HEPTEM clotting time ratio (I/Hr), as a bedside alternative to ACT. A total of 79 patients undergoing LTx with intraoperative ECMO support were analyzed. Unfractionated heparin was administered in all cases, and coagulation parameters were assessed preoperatively, before ECMO cannulation, and during ECMO support. A strong correlation was observed between I/Hr and anti-Xa, with satisfactory agreement with aPTT and aPTTr. Bland–Altman analysis confirmed narrower limits of agreement for I/Hr-derived versus ACT-derived anti-Xa predictions. These findings support I/Hr as a reliable and practical bedside surrogate for UFH monitoring during ECMO-assisted LTx.
- 31 May 2025
- Published by Elsevier in Transplant Immunology
- Vol. 92, 102245
Early post-lung transplant cell-free DNA levels are associated with baseline lung allograft dysfunction
- 31 May 2025
- Published by Elsevier in Transplant Immunology
- Vol. 92, 102245
Early post-lung transplant cell-free DNA levels are associated with baseline lung allograft dysfunction
- 1 April 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (7) , 1452-1460
Respiratory syncytial virus prefusion F3 vaccine in lung transplant recipients elicits CD4+ T cell response in all vaccinees
- 1 April 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (7) , 1452-1460
Respiratory syncytial virus prefusion F3 vaccine in lung transplant recipients elicits CD4+ T cell response in all vaccinees
- Open Access
- 18 February 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 20 (1) , 1-5
Bilateral lung herniation with parenchymal infarction following clamshell thoracotomy for lobar lung transplantation: a case report
Background: Pulmonary hernia is a rare condition characterized by the protrusion of lung tissue through a chest wall defect. Trauma and thoracic surgery are the most common causes of acquired lung hernias. We present an unusual case of (sequential) bilateral lung herniation with parenchymal infarction after bilateral lobar lung transplantation. Case presentation: A 50-year-old female, wait-listed as high-urgency candidate, with a body mass index (BMI) of 29 kg/m2 underwent a bilateral lobar lung transplantation for pulmonary fibrosis through a clamshell thoracotomy approach. Due to a size mismatch, stapler resection of the segment 3 and the middle lobe of the right lung, as well as an upper left lobectomy was required. The chest was closed with 3 braided non-absorbable pericostal sutures on each side. Sternal osteosynthesis was performed with a titanium sternal splint along with 7 self-tapping screws with a length of 18 mm. On the posttransplant day (PTD) 18, patient’s clinical condition deteriorated. Physical examination didn’t reveal any palpable subcutaneous chest resistance. However, a computed tomography (CT) scan showed a herniation of the segment 6 of the right lung. During acute surgical revision, perioperative finding revealed posterior pericostal suture failure. Therefore, a stapler resection was performed due to the infarction of the herniated segment. On the PTD 36, herniation of the left lung parenchyma was detected by acute CT scan. The protruding vital parenchyma was surgically repositioned without necessity of resection. Two posterior pericostal sutures were broken, and distal part of sternal splint detached. Thoracotomy was closed using 5 braided non-absorbable sutures. Sternum was re-osteosynthesized with the STRATOS™ system. After 3 months of intensive postoperative care, the patient was transferred to the rehabilitation department. She was discharged on the PTD 99. After 20 months of follow-up, lung function remains stable without the need for oxygen support. Conclusion: Clamshell incision remains ultimate approach in thoracic surgery. However, pulmonary herniation after clamshell thoracotomy is a rare complication and may manifest as acute respiratory distress syndrome with an inflammatory response. In these cases, CT scan should be always considered, even if no palpable pathology of chest is present.
- 18 February 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 20 (1) , 1-5
Open AccessBilateral lung herniation with parenchymal infarction following clamshell thoracotomy for lobar lung transplantation: a case report
Background: Pulmonary hernia is a rare condition characterized by the protrusion of lung tissue through a chest wall defect. Trauma and thoracic surgery are the most common causes of acquired lung hernias. We present an unusual case of (sequential) bilateral lung herniation with parenchymal infarction after bilateral lobar lung transplantation. Case presentation: A 50-year-old female, wait-listed as high-urgency candidate, with a body mass index (BMI) of 29 kg/m2 underwent a bilateral lobar lung transplantation for pulmonary fibrosis through a clamshell thoracotomy approach. Due to a size mismatch, stapler resection of the segment 3 and the middle lobe of the right lung, as well as an upper left lobectomy was required. The chest was closed with 3 braided non-absorbable pericostal sutures on each side. Sternal osteosynthesis was performed with a titanium sternal splint along with 7 self-tapping screws with a length of 18 mm. On the posttransplant day (PTD) 18, patient’s clinical condition deteriorated. Physical examination didn’t reveal any palpable subcutaneous chest resistance. However, a computed tomography (CT) scan showed a herniation of the segment 6 of the right lung. During acute surgical revision, perioperative finding revealed posterior pericostal suture failure. Therefore, a stapler resection was performed due to the infarction of the herniated segment. On the PTD 36, herniation of the left lung parenchyma was detected by acute CT scan. The protruding vital parenchyma was surgically repositioned without necessity of resection. Two posterior pericostal sutures were broken, and distal part of sternal splint detached. Thoracotomy was closed using 5 braided non-absorbable sutures. Sternum was re-osteosynthesized with the STRATOS™ system. After 3 months of intensive postoperative care, the patient was transferred to the rehabilitation department. She was discharged on the PTD 99. After 20 months of follow-up, lung function remains stable without the need for oxygen support. Conclusion: Clamshell incision remains ultimate approach in thoracic surgery. However, pulmonary herniation after clamshell thoracotomy is a rare complication and may manifest as acute respiratory distress syndrome with an inflammatory response. In these cases, CT scan should be always considered, even if no palpable pathology of chest is present.
- Open Access
- 1 October 2024
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (10) , 6863-6878
Treatment approaches and outcomes of major chest wall resections and reconstructions in patients with soft tissue and bone sarcomas: a retrospective observational study
Background: Chest wall sarcomas are rare and pose significant technical challenges in surgical management, particularly in patients with advanced disease. In this study, we examined the extent of resection, reconstruction techniques, and oncological outcomes of patients with chest wall soft tissue and bone sarcomas. Methods: This retrospective single-center series included patients who underwent surgery at our center between May 2014 and February 2022 for deep-seated/subfascial primary and recurrent soft tissue or bone sarcomas of the chest wall requiring significant resection and extensive reconstruction. We analyzed clinical and operative data, including extent of resection, reconstruction techniques, and oncological outcomes. Additionally, we compared survival outcomes between patients with primary and recurrent tumors, and examined how these were influenced by clinical factors using Cox proportional hazards regression analysis. Results: Of the 38 patients included, 22 were treated for primary or recurrent soft tissue sarcoma (STS) and 16 for bone sarcoma. En bloc microscopic radical resection (R0) was achieved in 95.45% and 93.75% of patients with soft tissue and bone sarcomas, respectively. Nonetheless, local recurrence or distant metastases occurred in 40%, 58.33%, and 40% of patients with primary soft tissue, recurrent soft tissue, and bone sarcomas, respectively. Adherence to clinical guidelines and treatment in the reference center was high for bone sarcoma (93.75%), but notably low for STS, resulting in 54.55% of these patients requiring re-resection. Compared with those who underwent only one surgery, patients who underwent re-resection had poorer postoperative outcomes, more severe complications, and longer hospital stay. Conclusions: Chest wall sarcomas often require extensive resection and complex reconstruction. Although surgical treatment at reference sarcoma centers has significantly improved oncological and clinical outcomes, the prognosis of these patients remains guarded, necessitating further related research and continued refinement in surgical techniques, adjuvant therapies, and follow-up strategies.
- 1 October 2024
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (10) , 6863-6878
Open AccessTreatment approaches and outcomes of major chest wall resections and reconstructions in patients with soft tissue and bone sarcomas: a retrospective observational study
Background: Chest wall sarcomas are rare and pose significant technical challenges in surgical management, particularly in patients with advanced disease. In this study, we examined the extent of resection, reconstruction techniques, and oncological outcomes of patients with chest wall soft tissue and bone sarcomas. Methods: This retrospective single-center series included patients who underwent surgery at our center between May 2014 and February 2022 for deep-seated/subfascial primary and recurrent soft tissue or bone sarcomas of the chest wall requiring significant resection and extensive reconstruction. We analyzed clinical and operative data, including extent of resection, reconstruction techniques, and oncological outcomes. Additionally, we compared survival outcomes between patients with primary and recurrent tumors, and examined how these were influenced by clinical factors using Cox proportional hazards regression analysis. Results: Of the 38 patients included, 22 were treated for primary or recurrent soft tissue sarcoma (STS) and 16 for bone sarcoma. En bloc microscopic radical resection (R0) was achieved in 95.45% and 93.75% of patients with soft tissue and bone sarcomas, respectively. Nonetheless, local recurrence or distant metastases occurred in 40%, 58.33%, and 40% of patients with primary soft tissue, recurrent soft tissue, and bone sarcomas, respectively. Adherence to clinical guidelines and treatment in the reference center was high for bone sarcoma (93.75%), but notably low for STS, resulting in 54.55% of these patients requiring re-resection. Compared with those who underwent only one surgery, patients who underwent re-resection had poorer postoperative outcomes, more severe complications, and longer hospital stay. Conclusions: Chest wall sarcomas often require extensive resection and complex reconstruction. Although surgical treatment at reference sarcoma centers has significantly improved oncological and clinical outcomes, the prognosis of these patients remains guarded, necessitating further related research and continued refinement in surgical techniques, adjuvant therapies, and follow-up strategies.
- Open Access
- 25 July 2024
- Published by Association for Computing Machinery (ACM)
- p. 1-2
Fitting Room: Lung Transplantation Donor-Recipient Size-matching in Virtual Reality
- 25 July 2024
- Published by Association for Computing Machinery (ACM)
- p. 1-2
Open AccessFitting Room: Lung Transplantation Donor-Recipient Size-matching in Virtual Reality
- 21 October 2023
- Published by Elsevier in Transplant Immunology
- Vol. 81, 101938
Effect of SARS-CoV-2 infection on anti-HLA antibodies and de novo donor specific antibodies incidence in lung transplant recipients
- 21 October 2023
- Published by Elsevier in Transplant Immunology
- Vol. 81, 101938
Effect of SARS-CoV-2 infection on anti-HLA antibodies and de novo donor specific antibodies incidence in lung transplant recipients